Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study
A Randomized Longitudinal Intervention Study to Assess Whether Electronic Messaging Can Increase Human Papilloma Viruses (HPV) Vaccine Utilization and Adherence Among Adolescents in Eastern North Carolina.
1 other identifier
interventional
522
1 country
2
Brief Summary
There has been very limited research that has looked at electronic reminders (text messages) and its effectiveness in adherence to vaccination among low-income minority populations. Results have shown that text messages, among low-income parents and adolescents who were identified as having a cellphone, is an effective strategy to increase the likelihood of adolescent vaccination adherence. Hard copy and electronic messaging reminders have also been proven to be effective when coupled with other prevention strategies for immunizations for influenza and pneumococcal pneumonia and screening for colon, breast, and cervical cancer in adults. Additionally, Merck and Co. recommend electronic reminders in their patient compliance program as a key strategy for adherence. To our knowledge, this community-based pilot intervention study will be the first to assess electronic reminders and HPV vaccine initiation and adherence among rural uninsured and Medicaid populations. The investigators hypothesize that adolescent whose parents who receive the intervention will be more likely to initiate HPV vaccination and be compliant at 3 months and at 7 months as compared to the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2013
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2013
CompletedFirst Posted
Study publicly available on registry
July 25, 2013
CompletedStudy Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedMay 25, 2016
May 1, 2016
2.8 years
July 15, 2013
May 23, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vaccine Adherence, as measure by receiving the 3 recommended doses withing a 6 month time period.
Vaccine adherence will be measured using the CDC's guidelines which state that the second dose be given one to two months after the first, and the third dose be given six months after the first dose.
7 months after initial HPV Vaccince shot
Secondary Outcomes (1)
HPV Knowledge, as measured by a 20% increase in knowledge about HPV and HPV vaccine among the intervention group.
7 months after the first initial HPV vaccine shot
Study Arms (1)
HPV Vaccine Electronic Reminders
EXPERIMENTALParents in the intervention group will receive 1 electronic message per month in addition to the baseline and final assessments which equates to 8 contacts over a 7 month period. Specifically, intervention group participants will receive 4 education messages, 2 reminder/education messages, as well as 1 baseline and 1 final assessment survey.
Interventions
The intervention group will receive 4 education messages, 2 reminder/education messages, as well as 1 baseline and 1 final assessment survey. Control group participants will receive 2 contacts throughout the study, 1 at baseline and 1 at their final assessment survey. Up to two reminder contacts will be used if surveys are not completed for both intervention and control group participants. Preference for receipt of reminders will be obtained from the information study card parents complete at study enrollment. Enrollment card content, educational messages and patient- reminders will all be developed with community input.
Eligibility Criteria
You may qualify if:
- Parent/Caretaker has Medicaid or is Uninsured
- Parent/Caretaker has a child between 11- 18 y/o
- Parent/Caretaker should be able to read English or Spanish
- Parent/Caretaker should have a phone and/or email address to provide for the study
You may not qualify if:
- Parents who have children younger than 11 or older than 18 years of age
- Parents who are not currently uninsured or enrolled in Medicaid/Medicare.
- Parent/Caretaker's child who received the 1st dose of HPV vaccine before enrolling in study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
East Carolina University's General Pediatric Outpatient Clinic
Greenville, North Carolina, 27858, United States
Kate B. Reynolds Medical Center
Snow Hill, North Carolina, 28580, United States
Related Publications (1)
Richman AR, Torres E, Wu Q, Carlston L, O'Rorke S, Moreno C, Olsson J. Text and Email Messaging for Increasing Human Papillomavirus Vaccine Completion among Uninsured or Medicaid-insured Adolescents in Rural Eastern North Carolina. J Health Care Poor Underserved. 2019;30(4):1499-1517. doi: 10.1353/hpu.2019.0090.
PMID: 31680111DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Essie Torres, PhD, MPH
East Carolina University
- PRINCIPAL INVESTIGATOR
Alice Richman, PhD, MPH
East Carolina University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 15, 2013
First Posted
July 25, 2013
Study Start
August 1, 2013
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
May 25, 2016
Record last verified: 2016-05